Toft Group Completes Executive Search for Ascendis Pharma Inc. (NASDAQ: ASND) in Palo Alto, CA

Ascendis Pharma

Executive search firm Toft Group has placed Dr. Michael Cohrs as Director of Clinical Quality at Ascendis Pharma in Palo Alto, CA. Prior to this role, he was a consultant within the biotech and pharmaceutical industries where his efforts focused on Quality Assurance, Quality Control, Quality Systems and Validation from early stage drug development through commercialization. He earned his PhD in Organic Chemistry from Washington University and an MBA from the University of Chicago.

About Ascendis Pharma Inc.

Ascendis Pharma is a clinical stage biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs.